Associate Professor, University of Chicago Medicine
Orthopaedic Surgery
Dr. Hue H. Luu, MD
|
|
Give Review
Hue H. Luu, MD is an expert in the field of Orthopaedic Surgery. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". Hue H. Luu, MD is also a published physician. He has 67 paper published. The most recent paper is: Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. He accepts all Medicare patients.
Publications
- Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering.
- Insider information: Testing cancer drug sensitivity for personalized therapy.
- Molecular pathogenesis and therapeutic strategies of human osteosarcoma.
- Modified Protocol Decreases Surgical Site Infections after Total Knee Arthroplasty.
- Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system.
- Targeting BMP9-Promoted Human Osteosarcoma Growth by Inactivation of Notch Signaling.
- BMP9 Effectively Induces Osteo/Odontoblastic Differentiation of the Reversibly Immortalized Stem Cells of Dental Apical Papilla (SCAPs).
- IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.
- Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors.
- Wnt signaling in bone formation and its therapeutic potential for bone Diseases.
- Conditional Immortalization Establishes a Repertoire of Mouse Melanocyte Progenitors with Distinct Melanogenic Differentiation Potential.
- Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells.
- Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.
- Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.
- TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
- Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
- Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.
- Therapeutic Implications of PPARgamma in Human Osteosarcoma.
- Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
- Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.
- Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells.
- A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells.
- Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
- Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects.
- S100A6 expression and function in human osteosarcoma.
- Regulation of osteogenic differentiation during skeletal development.
- BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury.
- Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.
- Wnt signaling and human Diseases: what are the therapeutic implications?
- Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
- CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
- Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
- Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells.
- Dual regulation of gene expression mediated by tetracycline and Cre recombinase.
- Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12.
- Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
- Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).
- Hip-vagina fistula after acetabular revision.
- A Simplified and Versatile System for the Simultaneous Expression of Multiple siRNAs in Mammalian Cells Using Gibson DNA Assembly.
- The piggyBac Transposon-Mediated Expression of SV40 T Antigen Efficiently Immortalizes Mouse Embryonic Fibroblasts (MEFs).
- Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene.
- Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids.
- BMP9 signaling in stem cell differentiation and osteogenesis.
- Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immun...
- Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.
- Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
- Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
- Identification of a novel metastasis-suppressor region on human chromosome 12.
- An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.
- Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.
- Wnt/beta-catenin signaling pathway as a novel cancer drug target.
- Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
- Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells.
- Establishment and characterization of a new highly metastatic human osteosarcoma cell line.
- BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling.
- A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.
- Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.
- The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.
- Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.
- BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential.
- Defective osteogenic differentiation in the development of osteosarcoma.
- Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials.
- Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
- Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation.
- Mesenchymal stem cells: Molecular characteristics and clinical applications.
- The therapeutic potential of the Wnt signaling pathway in bone disorders.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
University Of Chicago Hosps
Procedures Preformed
- Excision of Femur or Knee
- Excision of Radius or Ulna
- Excision of Scapula, Clavicle, Rib, or Sternum
- Excision of Tibula or Fibula
- View All
Conditions Treated
- Adhesive Capsulitis
- Ankle Fracture
- Ankle Sprain and Achilles Tendon Sprain or Rupture
- Arm Fracture (incl. Elbow and Shoulder)
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER | 1295757011 | |
| NPPES Provider LastName | LUU | |
| NPPES Provider FirstName | HUE | |
| NPPES Provider ZIPCode | 606371447 | |
| NPPES Provider State | IL | |
| Specialty Description | Orthopedic Surgery | |
| Total Claim Count | 478.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 155.0 | |
| Percent Opioid Claims | 32.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295757011 |
| Last Name Of The Provider | LUU |
| First Name Of The Provider | HUE |
| View All |
Similar Doctors
|
|
Dr. Michael Terry, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Benjamin Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frank Minardi, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Randon C. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Stover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clare R. Giegerich, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Snitovsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jozef Murar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Nickoli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam Edelstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Pastor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Switaj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol L. Prchal, MD |